A Japanese Earth-imaging satellite rode an Electron rocket into orbit today, giving Rocket Lab its 97th mission to date and its 18th orbital launch of 2026 — a cadence that lands just as the company finishes reshaping how it pays for its biggest acquisition yet.
The mission, flown under the name “Owlright Owlright Owlright,” deployed Synspective’s 13th StriX satellite at an altitude of 559 kilometers. The Japanese customer’s commitment stretches well past this flight: 14 more dedicated Electron launches are booked through the end of the decade, according to the company.
That kind of repeat business matters in the small-payload market, where proven launch frequency translates into predictable revenue and keeps the rocket line busy. It is also the operational backdrop against which investors have re-engaged with the stock. Rocket Lab closed Friday at EUR 64.90, sitting 7.7% above its 50-day moving average and up 15% over the past seven days.
Equity Replaces a Costly Bridge
The financing story behind Rocket Lab’s planned Iridium takeover came together in mid-September, when the company raised roughly $1.944 billion gross through an at-the-market share sale. The issuance of 29.3 million new shares diluted existing holders, but it allowed management to scrap entirely the $3.6 billion primarily secured bridge facility that had originally been arranged.
For creditors, that swap was the real all-clear signal. Replacing expensive debt with equity eases near-term balance-sheet pressure — a meaningful cushion given that the Iridium transaction is not expected to close until mid-2027, pending regulatory approvals. Lenders have already signed off on Iridium’s existing $1.775 billion credit facilities, with Rocket Lab USA set to assume an unsecured guarantee upon completion.
Wall Street has taken notice. Cantor Fitzgerald reaffirmed its Overweight rating on Monday and set a $122 price target, a vote of confidence in the long-term earnings power of a business that now spans rocket manufacturing, satellite platforms and future constellation services. Building the launch vehicle and operating the payload platforms in-house gives Rocket Lab a depth of vertical integration that is rare in commercial space.
Should investors sell immediately? Or is it worth buying Rocket Lab?
New Solar Tech, and a Fight Over a NASA Contract
The company is widening its technological footprint beyond launch. About three weeks ago it unveiled IMM Apex, a space solar cell that does away with germanium substrates entirely, reducing reliance on scarce mineral inputs in the manufacturing chain.
Rocket Lab has also shown it will push back on the institutional front. Roughly two weeks ago it filed a formal protest with the U.S. Government Accountability Office over NASA’s award of a $700 million Mars Telecommunications Network contract to rival Blue Origin.
Integration Risk Cuts Both Ways
The strategic logic behind the transformation — from pure-play launch specialist to vertically integrated space company — is bold, and the market has largely looked past the risks it carries. Absorbing an established communications network will tie up enormous management capacity for years, and the space industry is famously unforgiving of operational stumbles in day-to-day execution.
Still, the early cleanup of the financing structure has defused the single largest cluster of risk. As long as the core launch business keeps delivering, the company looks positioned to defend its strengthened market standing. For shareholders, the more useful focus is disciplined execution of the long-term buildout rather than the size of any single week’s rally.
Ad
Rocket Lab Stock: Buy or Sell?! New Rocket Lab Analysis from September 26 delivers the answer:
The latest Rocket Lab figures speak for themselves: Urgent action needed for Rocket Lab investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 26.
Rocket Lab: Buy or sell? Read more here...
